Coming Soon! NIDDK-CR is revising its policy to align with the final NIH Data Management and Sharing (DMS) policy and NIDDK DMS guidance.
Skip to Main Content
Home
chevron_right Studies chevron_right Ancillary Studies
chevron_right Rituximab for treatment of Type 1 diabetes: Impact on JC viral replication
Rituximab for treatment of Type 1 diabetes: Impact on JC viral replication
Main study |
The Effects of Rituximab on the Progression of Type 1 Diabetes in New Onset Subjects |
Contact name |
Vicky Slunaker, Grants Manager |
Contact phone |
317-274-8270 |
Contact email |
vslunake@iupui.edu |
Dua signed dt |
March 24, 2011, midnight |
PI name |
Eric Wiebke, MD (Ship samples to Co-I, Adriana Weinberg, MD) |
Site approved dt |
May 28, 2010, midnight |
Niddk signed dt |
June 2, 2011, midnight |
Owner |
Sarah Muller |
Lab name |
Benita (Bennie) Book |
Lab email |
bbook@iupui.edu |
Lab phone |
317-274-2646 |
Address |
University of Colorado Denver , Pediatric Infectious Diseases, 12700 E. 19th Avenue, Research 2, Mail Stop 8604, Office 11124, Lab11480 |
City |
Aurora |
State |
CO |
Zip code |
80045 |